Neurology:氨氯地平反应性三叉神经痛——病例报道

2017-08-15 杨中华 脑血管病及重症文献导读

氨氯地平减轻三叉神经痛的机制:电压门控钙通道能够减轻血管迂曲,以及N型通道(交感调节/镇痛作用)的作用。

氨氯地平减轻三叉神经痛的机制:电压门控钙通道能够减轻血管迂曲,以及N型通道(交感调节/镇痛作用)的作用。

55岁,女性,长期左侧下面部反复电击样疼痛。

因为发现高血压开始服用氨氯地平,服药后疼痛明显缓解。有时候漏服氨氯地平后疼痛复发。

脑MRI显示迂曲的血管压迫了左侧延髓前外侧和左侧三叉神经根。FIESTA序列显示左侧椎动脉(白色箭头)临近延髓前外侧(A图和B图)。MRA显示与右侧椎动脉相比,左侧椎动脉(白色箭头)行程比较局限(C图):



小脑前下动脉袢(红色箭头)临近左侧三叉神经根(白色箭头)(D-F图)。另外一支血管临近左侧三叉神经根的远侧(弯曲箭头)(E图):



作者认为氨氯地平减轻三叉神经痛的机制:电压门控钙通道能够减轻血管迂曲,以及N型通道(交感调节/镇痛作用)的作用。

文献出处:

R Uniyal , VK Paliwal , N Kumar ,et,al.Teaching NeuroImages: Amlodipine-responsive trigeminal neuralgia: An alibi for vascular compression theory.doi: 10.1212/WNL.0000000000004116.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000073, encodeId=501b20000e369, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Apr 27 11:13:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022790, encodeId=5a1e2022e9042, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Mar 02 10:13:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739254, encodeId=cd3e1e3925424, content=<a href='/topic/show?id=6a9f1959e07' target=_blank style='color:#2F92EE;'>#三叉神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19597, encryptionId=6a9f1959e07, topicName=三叉神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19e234497376, createdName=小华子, createdTime=Sun Mar 18 05:13:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341280, encodeId=24e81341280bd, content=<a href='/topic/show?id=20bf640515d' target=_blank style='color:#2F92EE;'>#氨氯地平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64051, encryptionId=20bf640515d, topicName=氨氯地平)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410749, encodeId=5b331410e4982, content=<a href='/topic/show?id=7dad19600f8' target=_blank style='color:#2F92EE;'>#三叉神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19600, encryptionId=7dad19600f8, topicName=三叉神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f67c2785166, createdName=yangeasy, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540818, encodeId=c849154081877, content=<a href='/topic/show?id=ac8de440615' target=_blank style='color:#2F92EE;'>#神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74406, encryptionId=ac8de440615, topicName=神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d8213287489, createdName=贵阳, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
    2018-04-27 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2000073, encodeId=501b20000e369, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Apr 27 11:13:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022790, encodeId=5a1e2022e9042, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Mar 02 10:13:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739254, encodeId=cd3e1e3925424, content=<a href='/topic/show?id=6a9f1959e07' target=_blank style='color:#2F92EE;'>#三叉神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19597, encryptionId=6a9f1959e07, topicName=三叉神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19e234497376, createdName=小华子, createdTime=Sun Mar 18 05:13:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341280, encodeId=24e81341280bd, content=<a href='/topic/show?id=20bf640515d' target=_blank style='color:#2F92EE;'>#氨氯地平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64051, encryptionId=20bf640515d, topicName=氨氯地平)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410749, encodeId=5b331410e4982, content=<a href='/topic/show?id=7dad19600f8' target=_blank style='color:#2F92EE;'>#三叉神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19600, encryptionId=7dad19600f8, topicName=三叉神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f67c2785166, createdName=yangeasy, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540818, encodeId=c849154081877, content=<a href='/topic/show?id=ac8de440615' target=_blank style='color:#2F92EE;'>#神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74406, encryptionId=ac8de440615, topicName=神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d8213287489, createdName=贵阳, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2000073, encodeId=501b20000e369, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Apr 27 11:13:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022790, encodeId=5a1e2022e9042, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Mar 02 10:13:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739254, encodeId=cd3e1e3925424, content=<a href='/topic/show?id=6a9f1959e07' target=_blank style='color:#2F92EE;'>#三叉神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19597, encryptionId=6a9f1959e07, topicName=三叉神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19e234497376, createdName=小华子, createdTime=Sun Mar 18 05:13:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341280, encodeId=24e81341280bd, content=<a href='/topic/show?id=20bf640515d' target=_blank style='color:#2F92EE;'>#氨氯地平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64051, encryptionId=20bf640515d, topicName=氨氯地平)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410749, encodeId=5b331410e4982, content=<a href='/topic/show?id=7dad19600f8' target=_blank style='color:#2F92EE;'>#三叉神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19600, encryptionId=7dad19600f8, topicName=三叉神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f67c2785166, createdName=yangeasy, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540818, encodeId=c849154081877, content=<a href='/topic/show?id=ac8de440615' target=_blank style='color:#2F92EE;'>#神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74406, encryptionId=ac8de440615, topicName=神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d8213287489, createdName=贵阳, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2000073, encodeId=501b20000e369, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Apr 27 11:13:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022790, encodeId=5a1e2022e9042, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Mar 02 10:13:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739254, encodeId=cd3e1e3925424, content=<a href='/topic/show?id=6a9f1959e07' target=_blank style='color:#2F92EE;'>#三叉神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19597, encryptionId=6a9f1959e07, topicName=三叉神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19e234497376, createdName=小华子, createdTime=Sun Mar 18 05:13:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341280, encodeId=24e81341280bd, content=<a href='/topic/show?id=20bf640515d' target=_blank style='color:#2F92EE;'>#氨氯地平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64051, encryptionId=20bf640515d, topicName=氨氯地平)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410749, encodeId=5b331410e4982, content=<a href='/topic/show?id=7dad19600f8' target=_blank style='color:#2F92EE;'>#三叉神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19600, encryptionId=7dad19600f8, topicName=三叉神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f67c2785166, createdName=yangeasy, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540818, encodeId=c849154081877, content=<a href='/topic/show?id=ac8de440615' target=_blank style='color:#2F92EE;'>#神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74406, encryptionId=ac8de440615, topicName=神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d8213287489, createdName=贵阳, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2000073, encodeId=501b20000e369, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Apr 27 11:13:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022790, encodeId=5a1e2022e9042, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Mar 02 10:13:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739254, encodeId=cd3e1e3925424, content=<a href='/topic/show?id=6a9f1959e07' target=_blank style='color:#2F92EE;'>#三叉神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19597, encryptionId=6a9f1959e07, topicName=三叉神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19e234497376, createdName=小华子, createdTime=Sun Mar 18 05:13:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341280, encodeId=24e81341280bd, content=<a href='/topic/show?id=20bf640515d' target=_blank style='color:#2F92EE;'>#氨氯地平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64051, encryptionId=20bf640515d, topicName=氨氯地平)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410749, encodeId=5b331410e4982, content=<a href='/topic/show?id=7dad19600f8' target=_blank style='color:#2F92EE;'>#三叉神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19600, encryptionId=7dad19600f8, topicName=三叉神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f67c2785166, createdName=yangeasy, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540818, encodeId=c849154081877, content=<a href='/topic/show?id=ac8de440615' target=_blank style='color:#2F92EE;'>#神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74406, encryptionId=ac8de440615, topicName=神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d8213287489, createdName=贵阳, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2000073, encodeId=501b20000e369, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Apr 27 11:13:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022790, encodeId=5a1e2022e9042, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Mar 02 10:13:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739254, encodeId=cd3e1e3925424, content=<a href='/topic/show?id=6a9f1959e07' target=_blank style='color:#2F92EE;'>#三叉神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19597, encryptionId=6a9f1959e07, topicName=三叉神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19e234497376, createdName=小华子, createdTime=Sun Mar 18 05:13:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341280, encodeId=24e81341280bd, content=<a href='/topic/show?id=20bf640515d' target=_blank style='color:#2F92EE;'>#氨氯地平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64051, encryptionId=20bf640515d, topicName=氨氯地平)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410749, encodeId=5b331410e4982, content=<a href='/topic/show?id=7dad19600f8' target=_blank style='color:#2F92EE;'>#三叉神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19600, encryptionId=7dad19600f8, topicName=三叉神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f67c2785166, createdName=yangeasy, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540818, encodeId=c849154081877, content=<a href='/topic/show?id=ac8de440615' target=_blank style='color:#2F92EE;'>#神经痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74406, encryptionId=ac8de440615, topicName=神经痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d8213287489, createdName=贵阳, createdTime=Thu Aug 17 02:13:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
    2017-08-17 贵阳

相关资讯

ASH 2014:与氨氯地平的降压药组合 奈必洛尔优于美托洛尔

美国高血压学会年会(ASH 2014)公布的一项研究表明,与氨氯地平/美托洛尔(A/M)相比,氨氯地平/奈必洛尔(A/N)在降低24小时动态血压(ABPM)方面具有优势,并且致患者足踝部水肿程度较轻。此项研究共纳入41例高血压成人患者,并启动4周氨氯地平(10 mg/d)单药治疗。随后添加4周小剂量奈必洛尔或美托洛尔治疗,并在后续4周强制滴定至大剂量奈必洛尔(20 mg/d)或美托洛尔(100 m

他们想从“4毛钱处方”中看到什么?

原标题《“4毛钱药方”治愈了谁?》 13日,一则#医生开4毛钱药#挺进微博热搜榜,从网友开骂只会开贵药的医生缺德,到医生大V们的无力吐槽,舆情在一天内现逆转。 事件还原医生开4毛钱药方治愈患者据10月12日华商报报道,西安刘女士的爱人王先生患有高血压,一直坚持服药。国庆出游回来,王先生的血压一直降不下去,吃降压药也不管用。10月7日晚11点多,他们到五二一医院挂急诊,医生只开了

钙拮抗剂为基础的联合降压效优

  发表于2012年第3期《中华高血压杂志》上研究表明,以钙拮抗剂氨氯地平为基础,联合替米沙坦或复方阿米洛利均能够降低高血压患者中心动脉压(CAP)、增强指数和改善大动脉顺应性,其中氨氯地平联合替米沙坦改善动脉弹性更明显,并且随着治疗时间的延长,效果更佳。   研究旨在探讨氨氯地平联合复方阿米洛利或联合替米沙坦对CAP和脉搏波传导速度(PWV)的影响。研究者们采用随机抽样方法选取2008-03-

Am J Kidney Dis:肾移植受者:氯噻酮VS氨氯地平哪个效果更好?

2017年6月,发表在《Am J Kidney Dis》的一项由荷兰科学家进行的研究,得出了氯噻酮与氨氯地平对于他克莫司治疗的肾移植受者降压等效的结论。

Lancet:不同体重人群的利尿剂降压治疗存在差异

     美国学者的一项研究表明,体重正常和肥胖患者的高血压可能经由不同机制介导。基于噻嗪类的治疗对体重正常患者的心血管保护作用可能逊色于肥胖患者,但基于氨氯地平的治疗则可在不同体质指数(BMI)患者中发挥相同效应。论文于2012年12月5日在线发表于《柳叶刀》(Lancet)。   此项研究基于BMI将ACCOMPLISH试验受试人群分为肥胖(BMI ≥30,n=570